TOSI, GIOVANNA
 Distribuzione geografica
Continente #
NA - Nord America 1.136
AS - Asia 207
EU - Europa 144
AF - Africa 7
SA - Sud America 6
OC - Oceania 5
Totale 1.505
Nazione #
US - Stati Uniti d'America 1.122
CN - Cina 114
VN - Vietnam 61
DE - Germania 57
IT - Italia 27
JP - Giappone 14
CA - Canada 12
GB - Regno Unito 11
RU - Federazione Russa 10
IE - Irlanda 9
CZ - Repubblica Ceca 6
IN - India 6
ZA - Sudafrica 6
AU - Australia 5
CL - Cile 5
NL - Olanda 5
SE - Svezia 5
HK - Hong Kong 4
UA - Ucraina 4
FR - Francia 3
GR - Grecia 2
KR - Corea 2
MX - Messico 2
SG - Singapore 2
AT - Austria 1
BR - Brasile 1
DZ - Algeria 1
EE - Estonia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
LU - Lussemburgo 1
MO - Macao, regione amministrativa speciale della Cina 1
PL - Polonia 1
TH - Thailandia 1
Totale 1.505
Città #
Fairfield 160
Houston 88
Ashburn 79
Buffalo 78
Woodbridge 74
Santa Cruz 70
Seattle 68
Cambridge 54
Dong Ket 45
Ann Arbor 41
Wilmington 38
Wuhan 30
Boardman 16
Beijing 15
University Park 14
Chicago 13
Shanghai 13
Dublin 9
Los Angeles 9
Ottawa 9
Phoenix 9
San Diego 9
Guangzhou 7
Nanjing 7
New York 7
Como 6
Henderson 6
Norwalk 6
San Francisco 6
Changsha 5
Herndon 5
Las Vegas 5
Ponte Lambro 5
Riva 5
Dallas 4
Easton 4
Muizenberg 4
San Jose 4
Tokyo 4
Auburn 3
Central 3
Lake Forest 3
Saint Petersburg 3
Scranton 3
Bengaluru 2
Cernusco 2
Clearwater 2
Fleming Island 2
Fremont 2
Hangzhou 2
Hillsborough 2
London 2
New Kensington 2
Pioltello 2
Silverton 2
Suzhou 2
Swansea 2
Toronto 2
Uppsala 2
Utrecht 2
Aci Catena 1
Alessandria 1
Athens 1
Atlanta 1
Bagheria 1
Bellevue 1
Boulder 1
Brooklyn 1
Budapest 1
Büdelsdorf 1
Carignan 1
Central District 1
Changchun 1
Chapel Hill 1
Charlton 1
Chengdu 1
Chennai 1
Chon Buri 1
Chongqing 1
Council Bluffs 1
Crugers 1
Cuauhtémoc 1
Denver 1
Durham 1
Exeter 1
Frankfurt Am Main 1
Fuzhou 1
Glasgow 1
Glenview 1
Groningen 1
Gustavo Adolfo Madero 1
Hebei 1
Hefei 1
Jakarta 1
Jersey City 1
Kiev 1
Kunming 1
Ludwigshafen 1
Lund 1
Mariestad 1
Totale 1.118
Nome #
Adequate Antigen Availability: A Key Issue for Novel Approaches to Tumor Vaccination and Tumor Immunotherapy, file e2188be6-038e-4564-e053-6605fe0a49d6 294
Proteomic analysis of dopamine and α-synuclein interplay in a cellular model of Parkinson's disease pathogenesis, file e2188be5-fed9-4564-e053-6605fe0a49d6 180
Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication, file e2188be5-fe84-4564-e053-6605fe0a49d6 129
Boosting the MHC class II-restricted tumor antigen presentation to CD4+ T helper cells: A critical issue for triggering protective immunity and re-orienting the tumor microenvironment toward an anti-tumor state, file e2188be6-0468-4564-e053-6605fe0a49d6 122
The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators, file e2188be6-02e1-4564-e053-6605fe0a49d6 120
Typing of a polymorphic human gene conferring susceptibility to insulin-dependent diabetes mellitus by picosecond-resolved FRET on non-purified/non-amplified genomic DNA, file e2188be6-01c0-4564-e053-6605fe0a49d6 111
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1., file e2188be6-00ef-4564-e053-6605fe0a49d6 106
MHC class II transactivator CIITA inhibits Tax-2-mediated HTLV-2 LTR transactivation and viral replication by binding to and affecting Tax-2 intracellular localization, file e2188be6-00f0-4564-e053-6605fe0a49d6 105
Time-Resolved Förster Resonance Energy Transfer Analysis of Single-Nucleotide Polymorphisms: Towards Molecular Typing of Genes on Non-Purified and Non-PCR-Amplified DNA, file e2188be6-02e7-4564-e053-6605fe0a49d6 97
The MHC class II transactivator (CIITA) mRNA stability is critical for the HLA class II gene expression in differentiating myelomonocytic cells., file e2188be5-fa6a-4564-e053-6605fe0a49d6 82
The MHC class II transactivator (CIITA): a "physiologic" drug against HIV-1 replication, file e2188be6-00f4-4564-e053-6605fe0a49d6 40
A dual defensive role of CIITA against retroviral infections, file e2188be6-016e-4564-e053-6605fe0a49d6 40
The molecular and cellular basis of tumor rejection after vaccination with mammary adenocarcinoma cells transduced with the MHC class II transactivator CIITA, file e2188be6-00f5-4564-e053-6605fe0a49d6 38
Insulin-dependent diabetes mellitus: A multistep autoimmune disease with multigene dependence, file e2188be5-fe90-4564-e053-6605fe0a49d6 22
I marcatori privilegiati delle malattie autoimmuni, file e2188be6-00ee-4564-e053-6605fe0a49d6 16
Studio sulle caratteristiche epidemiologiche e cliniche del diabete mellito insulino-dipendente ad insorgenza precoce, file e2188be5-fe98-4564-e053-6605fe0a49d6 15
DNA-Enzyme immunoassay: a rapid and sensitive method for HLA DQB1 and DQA1 molecular typing, file e2188be5-fe37-4564-e053-6605fe0a49d6 14
HLA-DQ typing for prediction of IDDM? Some "yes" people., file e2188be6-00ed-4564-e053-6605fe0a49d6 14
A dual defensive role of CIITA against retroviral infections, file e2188be6-016f-4564-e053-6605fe0a49d6 12
The MHC class II transactivator (CIITA): a physiologic inhibitor of HTLV-2 retroviral infection., file e2188be6-00f6-4564-e053-6605fe0a49d6 10
The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells, file e2188be6-6918-4564-e053-6605fe0a49d6 3
The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-kappa B by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein, file e2188be6-6b0d-4564-e053-6605fe0a49d6 3
Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP), file e2188be6-c595-4564-e053-6605fe0a49d6 3
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma, file e2188be7-2da9-4564-e053-6605fe0a49d6 3
The molecular basis of the inhibition of HTLV-2 retroviral replication by the MHC class II transactivator (CIITA), file e2188be6-0171-4564-e053-6605fe0a49d6 2
CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a TH1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory, file e2188be5-fb31-4564-e053-6605fe0a49d6 1
Therapy-induced antitumor vaccination by targeting tumor necrosis factor alpha to tumor vessels in combination with melphalan, file e2188be5-fbd0-4564-e053-6605fe0a49d6 1
HTLV-II Tax-2 increases the cell surface expression of HLA-II molecules by acting at the level of CIITA, the master regulator of HLA-II transcription, file e2188be6-016c-4564-e053-6605fe0a49d6 1
The MHC-II transactivator CIITA inhibits Tat-mediated HIV-1 LTR transactivation and virus replication in human U937 monocytic cells, file e2188be6-0195-4564-e053-6605fe0a49d6 1
Molecular and Cellular Correlates of the CIITA-Mediated Inhibition of HTLV-2 Tax-2 Transactivator Function Resulting in Loss of Viral Replication., file e2188be6-0287-4564-e053-6605fe0a49d6 1
CIITA-driven MHC class ii expressing tumor cells can efficiently prime naive CD4+ TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells, file e2188be6-c0d5-4564-e053-6605fe0a49d6 1
Totale 1.587
Categoria #
all - tutte 3.706
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.706


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019176 0 0 5 1 2 1 3 3 12 35 68 46
2019/2020383 40 24 37 60 27 31 35 37 36 14 16 26
2020/2021272 12 29 19 28 31 18 24 16 14 9 27 45
2021/2022400 35 41 17 29 53 18 21 27 14 12 100 33
2022/2023247 12 16 73 44 14 16 3 7 7 17 27 11
2023/202433 12 9 12 0 0 0 0 0 0 0 0 0
Totale 1.587